Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Tornier NV (NASDAQ:TRNX)

During the Trading Day
24.67 -0.22 / -0.88%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
24.67 0.00 / 0.00%
 
Volume: 1.1K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$1.2B

Company Description

Tornier NV is a global medical device company, which is focused on serving extremities specialists that treat orthopedic conditions of the shoulder, elbow, wrist, hand, ankle and foot. The company offers orthopedic reconstructive products in four major categories: Upper Extremity Joints and Trauma, Lower Extremity Joints and Trauma, Sports Medicine and Orthobiologics, and Large Joints and Other. It operates through orthopedic products segment, which includes the design, manufacture and marketing of joint implants and other related products. Tornier was founded in 2006 and is headquartered in Amsterdam, the Netherlands.

Contact Information

Tornier NV
Prins Bernhardplein 200
Amsterdam Noord-holland 1097 JB
P:(120) 675-4002
Investor Relations:

Employees

Shareholders

Mutual fund holders51.74%
Individual stakeholders28.35%
Other institutional22.18%

Top Executives

David H. MowryPresident, CEO & Executive Director
Shawn T. McCormickChief Financial Officer
Kevin M. KlemzSecretary, Chief Legal Officer & Senior VP
Stéphan EpinetteSenior VP-International Commercial Operations
Terry M. RichSenior Vice President-US Commercial Operations